We do have initial "Start Up" sales, obviously. Verséa Ophthalmics is telling us that each week.
What we don't know is the actual Monthly Reorder amount averaged per location.
It may take 2 or 3 10-Q reports to actually validate what the monthly reorder quantity will be. Unless we get some big announcements or press releases between now and August the share price might not move much.
However if the monthly reorder numbers are anywhere close to projections then the AXIM share price has to jump at some point. If AXIM becomes cash-flow positive and can I even Profitable, then we have a true growth story here that no one knows about.
I'm watching too. I might not have enough shares yet.
News 
Market Data 
Discover 
